Suchergebnisse - "Kamat, Aparna A"

PubPharm (81)

1

Author Correction : Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

enthalten in: Nature medicine | 2021

von Thaker, P. | Han, L. | Kamat, A. | +24

ErratumFor: Nat Med. 2006 Aug;12(8):939-44. - PMID 16862152

2

Editor's Note : The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Kamat, A. | Fletcher, M. | Gruman, L. | +6

ExpressionOfConcernFor: Clin Cancer Res. 2006 Mar 15;12(6):1707-14. - PMID 16551853

3

Correction : Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Halder, J. | Kamat, A. | Landen, C. | +12

ErratumFor: Clin Cancer Res. 2006 Aug 15;12(16):4916-24. - PMID 16914580

4

Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL

enthalten in: Cancer cytopathology | 2015

von Lyons, Y. | Kamat, A. | Zhou, H. | +4

5

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

enthalten in: Journal of the National Cancer Institute | 2013

von Merritt, W. | Lin, Y. | Spannuth, W. | +13

6

Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer

enthalten in: Journal of the National Cancer Institute | 2013

von Landen, C. | Lu, C. | Han, L. | +16

7

Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von Gillet, J. | Calcagno, A. | Varma, S. | +9

8

Multidrug ResistanceLinked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma

enthalten in: Clinical cancer research | 2012

von Gillet, J. | Calcagno, A. | Varma, S. | +9

9

Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

enthalten in: The Lancet. Oncology | 2011

von Coleman, R. | Duska, L. | Ramirez, P. | +12

CommentIn: Lancet Oncol. 2011 Nov;12(12):1082-3. - PMID 21992854

10

Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

enthalten in: The lancet / Oncology | 2011

von Coleman, R. | Duska, L. | Ramirez, P. | +12

1
2
3
4
5
6
7
8
9
Nächster »
[9]